|
|
|
|
Charter 4 |
Monday, 18:00 - 19:00 |
|
|
Sponsored Symposia
PCSK9 inhibition: LDL-C Lowering and Beyond – What the Cardiologist needs to know (This is an Amgen organised and funded symposium)
Talks |
|
|
|
|
|
|
|
Dyslipidaemia Management in 2017 - The Lower the Better? What is the role of the Cardiologist? |
Prof |
Alistair |
Hall |
|
|
|
|
Dyslipidaemia Management in 2017 - The Lower the Better? What is the role of the Cardiologist? |
Prof |
Alistair |
Hall |
|
|
|
|
PCSK9 inhibition with Evolocumab; from LDL-C reduction to plaque regression |
Dr |
Derek L |
Connolly |
|
|
|
|
|
|
|
|
|